Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA® (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With Inflammatory Bowel Disease Read more
‘The best news’: U.S. teenage hostage and her mother freed by Hamas are ‘doing very good,’ father says Read more
Canadian dollar seen rebounding as U.S. ties anchor domestic economy: Reuters poll By Reuters Read more